Skip to Main Content

Paper Details

Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial.
Int Psychogeriatr
16
2015
Author NameAffiliation
Anton P PorsteinssonAlzheimer's Disease Care,Research and Education Program (AD-CARE),University of Rochester School of Medicine and Dentistry,Rochester,New York,USA.
Jacobo E MintzerClinical Biotechnology Research Institute,Roper St. Francis Healthcare,Charleston,South Carolina,USA.
Peter V RabinsPsychiatry and Behavioral Sciences Johns Hopkins School of Medicine,Johns Hopkins Hospital,Baltimore,Maryland,USA.
Lon S SchneiderPsychiatry,Neurology,and Gerontology,Keck School of Medicine,University of Southern California,Los Angeles,California,USA.
Jerome A YesavageAging Clinical Research Center,Director Mental Illness Research Education and Clinical Center,VA Palo Alto Health Care System,Virginia,USA.
  • 1 - 5

Datasets